Menopause Treatment Market Analysis 2026

Market Dynamics of the Menopause Treatment Market

The rising prevalence of menopause at an early age is driving the menopause treatment.

One of the key drivers of the menopause treatment market is rising cases of menopause at an early age, leading people to reach out to menopause treatment options to overcome the symptoms. Normally, menopause is not likely to occur before the age of 51 years; however, some women may get early menopause or premature menopause. Premature menopause and early menopause are not the same but can be understood as the conditions where a woman or person assigned female at birth (AFAB) goes through menopause at an earlier age than is typically expected. 

Premature menopause is considered when menopause happens before age 40 whereas early menopause happens before age 45. As per clinical studies, menopause is not a process, but a natural condition hence can occur any at stage of life, however, the causes may vary. Early menopause occurs in about 5% of women or people with AFAB whereas premature menopause happens in about 1% of people with AFAB. 

In certain situations, cancer treatment, surgery, or specific health issues can cause both premature and early menopause. Other causes may include chemotherapy sessions, removal of ovaries, surgery that removes the uterus, family history of menopause at an early age, smoking cigarettes, autoimmune diseases, infections, drugs, HIV or AIDS, etc. All of these factors contribute to an increase in the number of occurrences of premature or early menopause, with more and more women seeking therapy, eventually propelling the market forward.

For instance, a survey conducted by the Indian National Family Health Survey (NFHS) during the years 2019-20, to understand the occurrence of premature and early menopause, including 724,115 females, excluding pregnant women or women lactating during the survey, as well as those who had experienced surgical menopause, and revealed that among the sample size, 429,446 women had experienced premature menopause and around 79,643 women experienced early menopause. Also, the prevalence analysis suggested that 2.23% of women between the ages of 15 and 39 experienced premature menopauses, while 16.2% of women between the ages of 40 to 44 experienced early menopause.
(Source: https://my.clevelandclinic.org/health/diseases/21138-premature-and-early-menopause)

Lack of awareness, health risks, and concerns like breast cancer related to hormonal replacement therapy restrict the market growth.

Hormonal replacement therapy (HRT), is a treatment that helps people to deal with the symptoms related to menopause. It usually helps to develop hormones that the body is no longer making., especially for people in their 30s or early 40s. This therapy is known to help relieve symptoms such as hot flashes, night sweats, mood swings, vaginal dryness, and reduced sex drive, as well as prevent postmenopausal osteoporosis. However, research published in the Saudi Medical Journal discovered that knowledge of HRT among the general female population was low (26.7%), and the usage of HRT was much lower (5%). Also, initial findings of the Women’s Health Initiative showed an increased risk of coronary heart disease (CHD) and breast cancer, which led to a decrease in the use of this therapy treatment. Also, other possible health risks include increased risk of uterine cancer, heart disease, blood clots and strokes, and gallbladder disease. Many of these risks sometimes are dependent on the person’s overall health and family history of health conditions however people still feel hesitant to overcome the fear of these risks and accept the treatment.

Aligning the technology with the menopause treatment procedure can widen the scope of market growth.

Alignment of technology has always resulted in improving productivity and efficiency of the work as it ensures that investments and initiatives are consistent with the company’s long-term goals and objectives. For instance, Telehealth combines telecommunications and virtual technology to deliver health care outside of traditional healthcare facilities, all supporting women to be proactive and take preventative healthcare measures.

Technology has already entered the menopause treatment market and is growing, however, a little more investment to perform research and development activities can help the market to grow further. Companies have been introducing numerous technology-linked menopause treatment options. 

For instance, FemTech has introduced a clothing brand linked with technology and innovative fabrics that can cool and wick away the moisture from hot flashes and night sweats, along with high-tech knickers to manage urinary leaks and periods. This includes OYA Femtech Apparel, 51 Apparel, and Nixi.

FemTech has also introduced wearable devices for managing menopause side-effects which will be helpful to women with different aspects of the impact of falling hormones from perimenopause onwards; helping to strengthen pelvic floors, dealing with leaks, and managing hot flashes.
(Source:https://www.positivepause.co.uk/menopause-blog/how-technology-can-help-manage-menopause#:~:text=Menopause%20telehealth%20%2D%20support%20when%20you,and%20take%20preventative%20healthcare%20measure.)

How did COVID–19 Impact the Menopause Treatment Market?

The COVID-19 pandemic caused a significant change to menopause service delivery. Since the eruption of the COVID-19 breakthrough and the declaration of lockdowns, many countries and companies experienced a severe disruption of health-service delivery, including gynaecological and menopause care. The necessity to maintain social distance and infection control policies led to the admission and development of telehealth services. Telehealth was perceived as feasible and acceptable by women, supporting the extension of a hybrid service delivery model incorporating telehealth and in-person consultation.

Thus, the pandemic has immensely affected the global healthcare system, however, it has also led to the introduction of a platform to promote and develop pioneering applications based on autonomic artificial intelligence technology with its therapeutic significance in combating the pandemic. AI has successfully demonstrated that it can reduce the human-to-human virus infectious probability through evaluation, analysis, and triangulation of existing data on the infectivity and spread of the virus. 
(Source: https://obgyn.onlinelibrary.wiley.com/doi/full/10.1111/ajo.13670)

Recent Developments

• At CES 2024, Menopause startup Amira launched The Terra System, a wearable cooling device that supports women battling hot flashes and helps them sleep through the night.

(Source: https://medcitynews.com/2024/01/menopause-startup-launches-ai-powered-hot-flash-care-product/) 

• On 5th March 2024: Bone Health Technologies (BHT), a health technology innovator developing breakthrough non-invasive solutions for bone health, today announced the company has raised a new $5 million funding round from leading investment firms This funding will prove to be a vital player in BHT’s mission to reshape bone health for postmenopausal women.

(Source: https://www.accesswire.com/839287/bone-health-technologies-secures-5-million-in-funding-to-transform-osteopenia-care) 

• On 17th April 2024: Included Health launches a virtual specialty care clinic with an initial focus on cancer, weight loss, and menopause.

(Source: https://www.fiercehealthcare.com/health-tech/included-health-launches-virtual-specialty-care-clinic-initial-focus-cancer-weight-loss) 

• July 2022: Mayo Clinic and Lisa Health signed a partnership contract to launch an app named Midday that leverages AI, sensor technology, and digital therapeutics to support menopause management and healthy aging. 

(Source: https://newsnetwork.mayoclinic.org/discussion/lisa-health-launches-midday-an-app-leveraging-ai-to-personalize-the-menopause-journey-in-collaboration-with-mayo-clinic/)

• On 19th February 2024: The Menopause Hub along with Zendra Health, announced the launch of an app that aims to provide individuals with a symptom tracker from their home. The app is also useful to monitor own menopausal and perimenopausal symptoms and receive medication reminders.

(Source: https://www.themenopausehub.ie/news/apprelease)

• On 31st August 2023: Female Engineering, Lindex's femtech brand, launched an innovative product category for menopausal women. The innovative garments with proprietary Anti-Flush™ Technology promise to relieve symptoms such as hot flushes and night sweats for women experiencing menopause.

(Source: https://about.lindex.com/press/news-and-press-releases/2023/lindexs-brand-female-engineering-launches-menopause-clothing-with-patented-technology/)

• In December 2023: Publicly-traded digital behavioral health company Talkspace announced a strategic partnership with menopause-focused telehealth startup Evernow.

(Source: https://www.mobihealthnews.com/news/talkspace-launches-partnership-evernow-womens-health)

With the help of the above study about the Menopause Treatment Market, it can be concluded that the market for Menopause Treatment worldwide is expected to develop significantly shortly. From the report, one can understand and infer the market dynamics, segmentations, status and trends, and key players in the market. It provides data regarding various topics such as market dimensions, prevailing trends, competitive landscape, and the outlook for prospective expansion. This allows the reader to understand and access reliable data about the market and industry.

Frequently Asked Questions (FAQs)